Bank of New York Mellon
TIL icon

Bank of New York Mellon’s Instil Bio TIL Stock Holding History

Bank of New York Mellon’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,300
Closed -$11.1K – 4381
2023
Q3 		$11.1K Hold
1,300
– – ﹤0.01% 4289
2023
Q2 		$14.3K Sell
1,300
-10,763
-89% -$132K ﹤0.01% 4316
2023
Q1 		$159K Hold
12,063
– – ﹤0.01% 3984
2022
Q4 		$152K Sell
12,063
-215
-2% -$10.6K ﹤0.01% 4047
2022
Q3 		$1.19M Buy
12,278
+2,516
+26% +$288K ﹤0.01% 3117
2022
Q2 		$902K Sell
9,762
-1,168
-11% -$165K ﹤0.01% 3273
2022
Q1 		$2.35M Sell
10,930
-323
-3% -$75.5K ﹤0.01% 2840
2021
Q4 		$3.85M Buy
11,253
+4,890
+77% +$1.89M ﹤0.01% 2605
2021
Q3 		$2.27M Buy
6,363
+444
+8% +$166K ﹤0.01% 2913
2021
Q2 		$2.29M Buy
5,919
+4,585
+344% +$1.7M ﹤0.01% 2901
2021
Q1 		$669K Buy
+1,334
New +$684K ﹤0.01% 3535

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon's TIL Position: Q4 2023 in Review

Bank of New York Mellon sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 1,300 shares — an estimated $11.1K sold.

Bank of New York Mellon first reported a position in TIL in Q1 2021 and held it in 11 quarters. The position peaked at $3.85M in Q4 2021. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

  • Bank of New York Mellon reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 1,300 Instil Bio shares in Q4 2023, an estimated $11.1K.
  • Bank of New York Mellon first reported a position in Instil Bio in Q1 2021 and held it in 11 quarters.
  • Bank of New York Mellon's Instil Bio position peaked at $3.85M in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.